Literature DB >> 16738317

Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo.

Kinh-Tung T Nguyen1, Panteha Tajmir, Chia Hung Lin, Nicole Liadis, Xu-Dong Zhu, Mohammed Eweida, Gunce Tolasa-Karaman, Fang Cai, Rennian Wang, Tadahiro Kitamura, Denise D Belsham, Michael B Wheeler, Akira Suzuki, Tak W Mak, Minna Woo.   

Abstract

PTEN (phosphatase with tensin homology) is a potent negative regulator of phosphoinositide 3-kinase (PI3K)/Akt signaling, an evolutionarily conserved pathway that signals downstream of growth factors, including insulin and insulin-like growth factor 1. In lower organisms, this pathway participates in fuel metabolism and body size regulation and insulin-like proteins are produced primarily by neuronal structures, whereas in mammals, the major source of insulin is the pancreatic beta cells. Recently, rodent insulin transcription was also shown in the brain, particularly the hypothalamus. The specific regulatory elements of the PI3K pathway in these insulin-expressing tissues that contribute to growth and metabolism in higher organisms are unknown. Here, we report PTEN as a critical determinant of body size and glucose metabolism when targeting is driven by the rat insulin promoter in mice. The partial deletion of PTEN in the hypothalamus resulted in significant whole-body growth restriction and increased insulin sensitivity. Efficient PTEN deletion in beta cells led to increased islet mass without compromise of beta-cell function. Parallel enhancement in PI3K signaling was found in PTEN-deficient hypothalamus and beta cells. Together, we have shown that PTEN in insulin-transcribing cells may play an integrative role in regulating growth and metabolism in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738317      PMCID: PMC1489140          DOI: 10.1128/MCB.00238-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes.

Authors:  R N Kulkarni; J C Brüning; J N Winnay; C Postic; M A Magnuson; C R Kahn
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

2.  Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase.

Authors:  C Postic; M Shiota; K D Niswender; T L Jetton; Y Chen; J M Moates; K D Shelton; J Lindner; A D Cherrington; M A Magnuson
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

3.  Disruption of IRS-2 causes type 2 diabetes in mice.

Authors:  D J Withers; J S Gutierrez; H Towery; D J Burks; J M Ren; S Previs; Y Zhang; D Bernal; S Pons; G I Shulman; S Bonner-Weir; M F White
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

4.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

5.  Normal growth and development in the absence of hepatic insulin-like growth factor I.

Authors:  S Yakar; J L Liu; B Stannard; A Butler; D Accili; B Sauer; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

Authors:  Yasuo Horie; Akira Suzuki; Ei Kataoka; Takehiko Sasaki; Koichi Hamada; Junko Sasaki; Katsunori Mizuno; Go Hasegawa; Hiroyuki Kishimoto; Masahiro Iizuka; Makoto Naito; Katsuhiko Enomoto; Sumio Watanabe; Tak Wah Mak; Toru Nakano
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

7.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

8.  PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance.

Authors:  Rohit N Kulkarni; Ulupi S Jhala; Jonathon N Winnay; Stan Krajewski; Marc Montminy; C Ronald Kahn
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

9.  Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus.

Authors:  Naoto Kubota; Yasuo Terauchi; Kazuyuki Tobe; Wataru Yano; Ryo Suzuki; Kohjiro Ueki; Iseki Takamoto; Hidemi Satoh; Toshiyuki Maki; Tetsuya Kubota; Masao Moroi; Miki Okada-Iwabu; Osamu Ezaki; Ryozo Nagai; Yoichi Ueta; Takashi Kadowaki; Tetsuo Noda
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

View more
  46 in total

1.  A PTEN translational isoform has PTEN-like activity.

Authors:  Xie Zhang; Bowei Yin; Fangfang Zhu; Guochang Huang; Hong Li
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

Review 2.  The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes.

Authors:  Jianling Xie; Terence P Herbert
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

3.  Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions.

Authors:  Linyuan Wang; Cynthia T Luk; Stephanie A Schroer; Alannah M Smith; Xie Li; Erica P Cai; Herbert Gaisano; Patrick E MacDonald; Zhenyue Hao; Tak W Mak; Minna Woo
Journal:  Diabetologia       Date:  2014-07-01       Impact factor: 10.122

4.  SIRT1 activation ameliorates hyperglycaemia by inducing a torpor-like state in an obese mouse model of type 2 diabetes.

Authors:  Richard E Gilbert; Kerri Thai; Suzanne L Advani; Carolyn L Cummins; David M Kepecs; Stephanie A Schroer; Minna Woo; Yanling Zhang
Journal:  Diabetologia       Date:  2015-01-07       Impact factor: 10.122

5.  PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice.

Authors:  José Iglesias; Sebastian Barg; David Vallois; Shawon Lahiri; Catherine Roger; Akadiri Yessoufou; Sylvain Pradevand; Angela McDonald; Claire Bonal; Frank Reimann; Fiona Gribble; Marie-Bernard Debril; Daniel Metzger; Pierre Chambon; Pedro Herrera; Guy A Rutter; Marc Prentki; Bernard Thorens; Walter Wahli
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

6.  Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes.

Authors:  Linyuan Wang; Yunfeng Liu; Shun Yan Lu; Kinh-Tung T Nguyen; Stephanie A Schroer; Akira Suzuki; Tak W Mak; Herbert Gaisano; Minna Woo
Journal:  Diabetes       Date:  2010-09-17       Impact factor: 9.461

7.  Critical role for hypothalamic mTOR activity in energy balance.

Authors:  Hiroyuki Mori; Ken Inoki; Heike Münzberg; Darren Opland; Miro Faouzi; Eneida C Villanueva; Tsuneo Ikenoue; David Kwiatkowski; Ormond A MacDougald; Martin G Myers; Kun-Liang Guan
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

8.  The retinoblastoma protein and its homolog p130 regulate the G1/S transition in pancreatic beta-cells.

Authors:  George Harb; Rupangi C Vasavada; David Cobrinik; Andrew F Stewart
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

9.  Insulin granule recruitment and exocytosis is dependent on p110gamma in insulinoma and human beta-cells.

Authors:  Gary M Pigeau; Jelena Kolic; Brandon J Ball; Michael B Hoppa; Ying W Wang; Thomas Rückle; Minna Woo; Jocelyn E Manning Fox; Patrick E MacDonald
Journal:  Diabetes       Date:  2009-06-23       Impact factor: 9.461

10.  Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors.

Authors:  Yi-Chieh Nancy Du; David S Klimstra; Harold Varmus
Journal:  PLoS One       Date:  2009-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.